Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks

Current treatment options for patients infected with hepatitis B virus (HBV) are suboptimal, because the approved drugs rarely induce cure due to the persistence of the viral DNA genome in the nucleus of infected hepatocytes, and are associated with either severe side effects (pegylated interferon-a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kyle E. Korolowicz, Manasa Suresh, Bin Li, Xu Huang, Changsuek Yon, Bhaskar V. Kallakury, Kyoung-pil Lee, Sungman Park, Yoon-Won Kim, Stephan Menne
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-09-01
coleção:	Cells
Assuntos:	vimentin humanized antibody hzVSF entry inhibitor tenofovir alafenamide fumarate hepatitis B virus
Acesso em linha:	https://www.mdpi.com/2073-4409/10/9/2321
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!